Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-06-13 to 2023-06-23
Current total value of award: $2286.6
Description: 8509951002!TYPHOID VI POLYSACC